Project description
Non-invasive cardiac arrhythmia ablation with proton therapy
Heart arrhythmia affects millions of people and the numbers are expected to grow due to the aging populations and lifestyle changes. The current standard catheter ablation procedure requires hospitalisation and has a high risk of complications, such as bleeding, infection, and damage to heart valves or blood vessels. Swiss EBAMed developed a non-invasive device, Cardio-kit, for the treatment of heart arrhythmia using proton therapy. It monitors the heart in real-time and automatically adjusts the stop/go signal to the proton therapy machine based on the cardiac cycle, providing accurate, effective and safe treatment of the moving target within the heart. The EU-funded Cardio-kit project will enable optimisation of the Cardio-kit hardware and software and start of clinical validation procedures necessary for commercialisation in Europe.
Fields of science
- medical and health sciencesclinical medicinecardiologycardiovascular diseasescardiac arrhythmia
- natural sciencescomputer and information sciencessoftware
- medical and health scienceshealth sciencespublic health
- medical and health sciencesclinical medicinesurgerysurgical procedures
- medical and health sciencesclinical medicineanaesthesiology
Programme(s)
Funding Scheme
SME-2b - SME Instrument (grant only and blended finance)Coordinator
1202 Geneve
Switzerland
See on map